Sfoglia per RIVISTA
BLOOD
Collezione ASL Vercelli

  

Items : 10

Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) As Salvage Therapy for Patients with Multiple Myeloma: Multicenter, Retrospective Clinical Experience with 262 Cases Outside of Controlled Clinical Trials in Blood

2024
ASL Vercelli

Martino EA; Derudas D; Rossi E; Terlizzi S; Reddiconto G; Stefanoni P; Micozzi J; Mangiacavalli S; Zamagni E; Offidani M; Furlan A; Buda G; Lotti F; Liberatore C; Lazzaro A; Della Pepa R; Bertuglia G; Barbieri E; Conticello C; De Magistris C; De Paoli L; Bongarzoni V; Cafro AM; Mele A; Benvenuti P; Cerchione C; Botta C; Antonioli E; Sgherza N; et alii...

Outcomes of Venetoclax Retreatment after MRD-Guided Venetoclax +/- Ibrutinib: Results of the Improve Study in Blood

2023
ASL Vercelli

Albi E; Scarfo L; Heltai S; Scarano E; Schiattone L; Farina L; Moia R; Deodato M; Ferrario A; Motta M; Noto A; Sancetta R; Coscia M; Rivela P; Laurenti L; Varettoni M; Perotta E; Capasso A; Ranghetti P; Martini F; Sant'Antonio E; Combi C; Colia M; Ghia P;

Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL. in Blood / Blood. 2022 Dec 1;140(22):2348-2357. doi: 10.1182/blood.2022016901.

2022
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara
ASL Vercelli

Ghia P; Colia M; Ranghetti P; Perotta E; Capasso A; Varettoni M; Laurenti L; Coscia M; Rivela P; Sancetta R; Motta M; Reda G; Ferrario A; Moia R; Deodato M; Farina L; Schiattone L; Albi E; Scarano E; Heltai S; Scarfò L;

Thrombotic and Bleeding Complications in Patients with Chronic Lymphocytic Leukemia and Severe COVID-19: A Study of Eric, the European Research Initiative on CLL in Blood

2022
ASL Vercelli

Antic D; Milic N; Chatzikonstantinou T; Scarfò L; Otasevic V; Rajovic N; Allsup D; Cabrero AA; Andres M; Baile Gonzales M; Capasso A; Collado R; Cordoba R; Cuéllar-García C; Correa JG; De Paoli L; De Paolis MR; Del Poeta G; Dimou M; Doubek M; Efstathopoulou M; El-Ashwah S; Enrico A; Espinet B; Farina L; Ferrari A; Foglietta M; Lopez-Garcia A; Garcia-Marco JA; et alii...

Safety and Efficacy of Rituximab Plus Bendamustine in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients in Blood

2014
ASL Vercelli

Arcari A; Chiappella A; Valenti V; Zanlari L; Tani M; Marasca R; Cabras MG; Spina M; Santagostino A; Ilariucci F; Carli G; Musto P; Savini P; Marino D; Ghio F; Gentile M; Cox MC; Della Seta R; Vallisa D;

Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study. in Blood / Blood. 2013 Oct 17;122(16):2799-806. doi: 10.1182/blood-2013-03-488676. Epub 2013 Aug 16.

2013
AOU Città della Salute di Torino
ASL Vercelli

Larocca A; Montefusco V; Bringhen S; Rossi D; Crippa C; Mina R; Galli M; Marcatti M; La Verde G; Giuliani N; Magarotto V; Guglielmelli T; Rota-Scalabrini D; Omedé P; Santagostino A; Baldi I; Carella AM; Boccadoro M; Corradini P; Palumbo A;

Evaluation of factor V Leiden, prothrombin mutations and the homozygous mutation 677T in the MTHFR gene in patients with venous thrombosis in Blood

2013
ASL Vercelli

Pizzuti M; Santagostino A; Antonietta Rizzo M; Dragonetti D; Pietrafesa MG; Attolico I; Amendola A; Filardi N; Cimminiello M; Matturro A; Vertone D; Nuccorini R; Pascale SP; Coluzzi S;

Association between immunoparesis and a skewed free light chain (FLC) ratio: A new prognostic factor of progression from mgus to multiple myeloma? in Blood

2013
ASL Vercelli

Pizzuti M; Santagostino A; Smaldore G; Chitarrelli I; Vertone D; Pascale SP; Matturro A; Attolico I; Amendola A; Cimminiello M; Filardi N; Girardi A; Penitente R; Nuccorini R; Coluzzi S; Scavone E;

Pomalidomide cyclophosphamide and prednisone (PCP) treatment for relapsed/refractory multiple myeloma in Blood

2012
ASL Vercelli

Palumbo A; Larocca A; Montefusco V; Rossi D; Carella AM; Mina R; Crippa C; Sciacca M; Galli M; Scalabrini DR; Marcatti M; Guglielmelli T; Giuliani N; La Verde G; Baldi I; Muccio VE; Boccadoro M; Corradini P;

A phase I/II study of pomalidomide-cyclophosphamide-prednisone (PCP) in patients with multiple myeloma relapsed/refractory to lenalidomide in Blood

2011
ASL Vercelli

Palumbo A; Larocca A; Carella AM; Rossi D; Montefusco V; Ferrari S; Santagostino A; Guglielmelli T; Galli M; Capaldi A; Giuliani N; Verde GL; Omedè P; Baldi I; Boccadoro M; Corradini P;